Results 51 to 60 of about 8,155 (200)
PLoS ONE, 2018 Antithyroid drugs are generally selected as the first-line treatment for Graves' Disease (GD); however, the existence of patients showing resistance or severe side effects to these drugs is an important issue to be solved. The (pro)renin receptor [(P)RR]
Yuki Mizuguchi +11 more
doaj +1 more source
Journal of Mid-Life Health, 2018 One of the major manifestations of methimazole-induced neutropenia or agranulocytosis is diffuse gingival ulceration and necrosis. The aim of this case report is to be familiar with drug-induced neutropenia and its associated oral manifestations and the ...
Ritika Arora +3 more
doaj +1 more source
Therapeutic plasmapheresis in patients with severe hyperthyroidism in whom antithyroid drugs are contraindicated [PDF]
, 2004 Four patients with Graves' disease in whom antithyroid drugs could not be used were treated by plasmapheresis preoperatively. On admission all patients had severe hyperthyroidism.
Gul, Nurdan +5 more
core +1 more source
Clinical Endocrinology, EarlyView.ABSTRACT Iodine deficiency, once considered eliminated in the United Kingdom, has re‐emerged, particularly among women of reproductive age, in whom requirements are increased during pregnancy and lactation. The declining consumption of dairy and white fish, the emerging use of unfortified plant‐based milk alternatives, and the absence of a national ...
Peter N. Taylor +11 more
wiley +1 more source
Extrathyroidal actions of Antithyroid Thionamides [PDF]
, 2002 Some compounds having thionamide structure inhibit thyroid functions. Such antithyroid thionamides include mercaptomethylimidazole (methimazole), thiourea and propylthiouracil, of which mercaptomethylimidazole is widely used to treat hyperthyroidism ...
Biswas, Kausik +2 more
core +1 more source
Thyroid Hemiagenesis Associated with Hashimoto’s Thyroiditis
Case Reports in Endocrinology, 2013 Thyroid hemiagenesis is a rare congenital anomaly resulting from failure of one thyroid lobe development. We report a 23-year-old female presented with Hashimoto’s thyroiditis in left lobe, associated with hemiagenesis of right lobe and isthmus which ...
D. Nsame +5 more
doaj +1 more source
Antithyroid drug-induced aplastic anemia [PDF]
, 2008 Background: Antithyroid drugs have been used for more than 50 years for the management of hyperthyroidism. Most patients tolerate treatment well but some may develop life threatening side effects such as agranulocytosis and aplastic anemia (AA).
Syriou, V. +5 more
core
Coordination behaviour of antithyroid drugs against the Fe(I)(NO)2 group in solution: ESR and FT-NMR study [PDF]
, 1978 The binding sites of some types of antithyroid drugs in the presence of the Fe(I)(NO)2 paramagnetic probe were investigated. Coordination behaviour in solution of different structured ligands was determined by means of ESR parameters and 13C FT-NMR ...
Basosi, R. +5 more
core +1 more source
Engineering Reports, Volume 8, Issue 8, August 2026.Our research establishes a hybrid feature selection and ensemble machine learning pipeline for the classification of euthyroid, hyperthyroid, hypothyroid, and subclinical hypo‐ and hyperthyroid disorders. Variance Threshold with Backward Feature Elimination attained nearly 100% accuracy, while SHAP and LIME clarified the significance of features and ...
Md. Minhajul Abedin +5 more
wiley +1 more source
HIGH THYROPEROXIDASE ANTIBODY TITERS MAY PREDICT RESPONSE TO ANTITHYROID DRUG TREATMENT IN GRAVES DISEASE: A PRELIMINARY STUDY [PDF]
, 2023 Background and aim. Antithyroid drugs are first treatment for Graves hyperthyroidism worldwide. Although remission can be achieved in approximately 40-50% of patients in 12-18 months with antithyroid drugs, this period can be extended up to 24 months. We
Firat, S. +6 more
core +1 more source